Search Tag: ESC Congress 2024
2024 02 Sep
Using optical coherence tomography (OCT) to guide stent implantation during percutaneous coronary intervention (PCI) in patients with complex coronary lesions significantly improves survival rates and reduces adverse cardiovascular events compared to the standard angiography-guided PCI, according to late-breaking research presented at the ESC...Read more
2024 02 Sep
A study comparing an invasive strategy with optimal medical therapy alone in older adults following a non-ST-elevation myocardial infarction (NSTEMI) found no impact on the combined risk of cardiovascular death or myocardial infarction (MI), despite reductions in non-fatal MIs and subsequent revascularisation procedures. This finding was presented...Read more
2024 02 Sep
According to research presented at the ESC Congress 2024 in London, screening for atrial fibrillation (AF) with a wearable heart monitor over a two-week period can identify older adults with this potentially dangerous heart rhythm disorder but does not reduce the risk of subsequent strokes. However, the trial was cut short due to the COVID-19...Read more
2024 31 Aug
Research presented at #ESCCongress2024 shows that tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation (TR) and improved quality of life after one year. TR can occur due to intrinsic abnormalities of the tricuspid valve (primary TR), remodelling of the right heart...Read more
2024 31 Aug
In two trials, including one involving frail elderly patients, evening administration of blood pressure (BP)--lowering medications showed no clinical benefits over morning administration, according to research presented at ESC Congress 2024. BP typically follows a circadian rhythm, peaking after waking and reaching its lowest point during...Read more
2024 30 Aug
New research presented at ESC Congress 2024 showed that discontinuing beta-blockers in patients with a history of myocardial infarction (MI) did not demonstrate cardiovascular safety compared to continuation and provided no improvement in patients' quality of life. Advancements in MI management and findings from observational studies have...Read more
2024 30 Aug
Late-breaking research presented at a Hot Line session at ESC Congress 2024 found no significant difference in major post-operative complications between patients who continued versus those who stopped renin-angiotensin system inhibitors (RASIs) before non-cardiac surgery. Many patients undergoing major surgery have a history of hypertension,...Read more
2024 30 Aug
The updated ESC Guidelines on managing elevated blood pressure and hypertension introduce a new "elevated BP" category, set more ambitious treatment targets, and, for the first time, recommend renal denervation for treating various forms of hypertension. Hypertension and elevated blood pressure are the most prevalent risk factors for heart...Read more
2024 30 Aug
The 2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases (PAAD) approach these vascular conditions as interconnected components of the cardiovascular system, acknowledging that patients with aortic diseases often have a concurrent risk of peripheral vascular diseases and vice versa. Although primarily aimed at cardiologists,...Read more